7[1]Kojima H,Yamao J,Tsujimoto T,et al.Mixed endothelin receptor antagonist,SB209670,decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance[J].J Hepatol,2000,32(1):43-50.
8[2]Schneider A W,Kalk J F,Klein C P.Effect of losartan,an angiotensin II receptor antagonist,on portal pressure in cirrhosis[J].Hepatology,1999,29(2):334-339.
9[3]Cales P,Oberti F,Payen J L,et al.Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis:a randomized trial.French-Speaking Club for the Study of Portal Hypertension[J].Eur J Gastroenterol Hepatol,1999,11(7):741-745.
10[4]Lebrec D.Review:pharmacotherapeutic agents in the treatment of portal hypertension[J].J Gastroenterol Hepatol,1997,12(2):159-166.
